has the participant ever experienced amyloid related imaging abnormalities-edema (aria-e), amyloid related imaging abnormalities-hemorrhage (aria-h), or other major adverse events associated with treatments expected to modify adrd biomarkers?

Draft

CDE Summary

Quick facts

Definition

No definition provided.

Notes

No notes.

Permissible Values

No permissible values specified.